Evaluation of maternal low-dose bromoform supplementation in late gestation on blood parameters of cows and their progeny

Bromoform supplementation has been successful in reducing enteric methanogenesis in ruminants; however, the impacts on the health of these animals, are still limited. The current study evaluates the impact of maternal low-dose bromoform supplementation on the health of late-gestation cows and their progeny. Pregnant Angus cows (n=42) were allocated into a control or bromoform group (n=21 cows per treatment). Bromoform extracted from Asparagopsis taxiformis (7.37mg/kg) was supplemented once daily. Blood samples were collected from cows before supplementation (baseline). Within 24h of parturition, blood and colostrum samples were collected from each cow and blood from neonates. Colostrum brix was measured to indicate immunoglobulin content. All data was analysed using a MIXED procedure in SAS. Supplementation of cows with bromoform resulted in increased blood urea to creatinine ratio (P=0.048), base excess (P=0.049), total carbon dioxide (TCO2; P=0.048) and a decrease in blood glutamate dehydrogenase (GLDH; P = 0.031) compared to the control group. For cows in the bromoform group, a trend was observed for higher levels of partial pressure of carbon dioxide (pCO2; P > 0.05) and bicarbonate (HCO3-; P = 0.052), and lower levels of partial pressure of oxygen (pO2; P = 0.058) compared to the control group. Blood gamma-glutamyl transferase (GGT) was elevated in offspring of cows fed bromoform (P = 0.050). The lower blood pO2 of pregnant cows fed bromoform and elevated blood GGT levels in offspring are not well understood and highlight the need for further investigation. Additionally, the low-dose bromoform supplementation affected various blood gas parameters of cows and calves, demonstrating the importance of monitoring these parameters when using different doses of halogenated compounds in livestock.

Novel postharvest processing strategies for value-added applications of marine algae

Marine algae are regarded as a promising nutrients resource in future as they can be sustainably cultured without land and high investment. These macroalgae are now widely processed into food and beverages, fertilizers and animal feed. Furthermore, bioactive compounds such as polysaccharides and polyphenols in seaweeds have proven to have antibacterial, antiviral and antifungal properties that can be utilized in cosmeceuticals, nutraceuticals and pharmaceuticals. As a key procedure in seaweed production, the postharvest process not only requires more laboured and energy but also affect the quality of the final product significantly. This article reviewed all current postharvest processes and technologies of seaweed and addressed potential postharvest strategies for seaweed production. © 2021 Society of Chemical Industry.

Seaweed dietary supplements enhance the innate immune response of the mottled rabbitfish, Siganus fuscescens

Disease is one of the major bottlenecks for aquaculture development, costing the industry in excess of US $6 billion each year. The increase in pressure to phase out some traditional approaches to disease control (e.g. antibiotics) is pushing farmers to search for alternatives to treat and prevent disease outbreaks, which do not have detrimental consequences (e.g. antibiotic resistance). We tested the effects of eleven seaweed species and four established fish immunostimulants on the innate immune response (cellular and humoral immunity) of the rabbitfish Siganus fuscescens. All supplements including different seaweeds from the three groups (Chlorophyta, Phaeophyta and Rhodophyta) were included in the fish pellet at 3% (by weight) and had variably positive effects across the four innate immune parameters we measured compared to control fish. Diets supplemented with the red seaweed Asparagopsis taxiformis and the brown seaweed Dictyota intermedia led to the largest boosts in humoral and cellular innate immune defences, including particularly significant increases in haemolytic activity. Diets supplemented with Ulva fasciata also led to promising positive effects on the fish innate immune responses. We conclude that dietary seaweed supplements can boost the immune response of S. fuscescens and thus the top three species highlighted in this study should be further investigated for this emerging aquaculture species and other fish species.

Effect of dietary inclusion of fermented sea mustard by-product on growth performance, blood profiles, and meat quality in broilers

BACKGROUND

Sea mustards are traditionally consumed as human food in many Asian countries. However, owing to the large consumption of seaweed, there are a substantial number of by-products produced during processing. These by-products after fermentation can provide a good alternative nutrient source for broilers and serve as a recycled resource reducing the environmental pollution of the seaweed industry. Therefore, an experiment was conducted to evaluate the effect of fermented sea mustard by-product (FSM) supplementation on growth performance, nutrient digestibility, excreta microflora, blood profiles, relative organ weight, and meat quality in broilers. The treatments were: control (CON), basal diet; FSM, CON +2 g kg^-1 FSM.

RESULTS

During days 1 to 35, with the supplementation of 2 g kg^-1 FSM, body weight gain (BWG) increased (P < 0.05), whereas the feed conversion ratio (FCR) decreased (P < 0.05). On day 35, with the supplementation of 2 g kg^-1 FSM, excreta Lactobacillus counts increased (P < 0.05), and the excreta Escherichia coli counts decreased (P < 0.05). There were no significant effects (P > 0.05) on nutrient digestibility, blood profile, relative organ weight, and breast meat quality of broilers fed with FSM diets.

CONCLUSION

Dietary supplementation of 2 g kg^-1 FSM can improve growth performance, and shifted excreta microflora by increasing the proliferation of Lactobacillus counts and by decreasing E. coli counts. © 2019 Society of Chemical Industry.